Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-231
TNBC
Basal B
GSK461364
PLK1
PLK
7893.001
uM
0.03312
0.01644
0.2564 0.4849 4.9996 0.2921
0.8605
2.3044
MDA-MB-231
TNBC
Basal B
GSK923295
CENPE
Kinesin
7892.001
uM
0.07006
0.05153
-0.0952 0.1660 1.3130 0.3922
0.9207
2.6314
MDA-MB-231
TNBC
Basal B
GSK923295
CENPE
Kinesin
7893.001
uM
0.09236
0.05367
0.0130 0.2306 1.1393 0.3696
0.9207
2.3044
MDA-MB-231
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7504.091
uM
20.47270
36.0860
-0.9636 -0.9970 1.9346 0.4817
0.9898
1.9941
MDA-MB-231
TNBC
Basal B
Ispinesib
KSP
Kinesin
7504.067
uM
0.09221
1.02460
-0.9685 -1.0000 0.4562 0.5660
0.8950
1.9544
MDA-MB-231
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7504.095
uM
0.00069
0.11642
-0.9613 -1.0000 0.2143 0.9276
0.7141
2.0796
MDA-MB-231
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7504.098
uM
inf
inf
1.0397 1.0397 0.0000 -0.0333
-0.9550
1.8959
MDA-MB-231
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7504.084
uM
inf
inf
1.0500 1.0500 0.0000 -0.0371
-3.9735
1.8866
MDA-MB-231
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
7504.066
uM
81.25090
65.26570
0.6427 0.3200 4.6641 -0.0184
0.8832
1.8487
MDA-MB-231
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7892.011
uM
59.00920
382.57620
-0.1767 -1.0000 0.5877 0.2215
0.9889
2.6182
MDA-MB-231
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7504.095
uM
inf
inf
0.9438 0.9438 0.0000 -0.0266
-0.1642
2.0796
MDA-MB-231
TNBC
Basal B
PS-1145
IKK
NFKB
7504.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0441
-20.3886
1.6220
MDA-MB-231
TNBC
Basal B
Purvalanol A
CDK1
CDK
7504.067
uM
inf
32.55750
0.5998 0.5789 1.7976 0.0345
0.9580
1.9544
MDA-MB-231
TNBC
Basal B
Sirolimus
MTOR
MTOR
7504.069
uM
inf
inf
1.0328 1.0328 0.0000 -0.0478
-66.7663
1.8361
MDA-MB-231
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7504.084
uM
inf
7.15930
0.7354 0.8400 4.8199 0.0437
0.7230
1.8866
MDA-MB-231
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7504.067
uM
8.21570
12.30310
-0.9685 -0.9683 2.6677 0.3604
0.9976
1.9544
MDA-MB-231
TNBC
Basal B
Taxol
TUBB
TUBB
7893.002
uM
0.0130
0.01253
-0.1441 0.0160 0.8926 0.5858
0.9687
2.3454
MDA-MB-231
TNBC
Basal B
Taxol
TUBB
TUBB
7892.002
uM
0.01991
0.01879
-0.0409 0.0326 1.1648 0.5459
0.9917
2.4193
MDA-MB-231
TNBC
Basal B
Topotecan
TOP1
TOP
7892.043
uM
inf
0.53315
0.7945 0.7749 0.5934 0.0977
0.7193
2.5944
MDA-MB-231
TNBC
Basal B
Topotecan
TOP1
TOP
7893.007
uM
1.16470
1.95450
-0.1181 -0.1989 0.6470 0.3749
0.9961
2.2909
MDA-MB-231
TNBC
Basal B
Trametinib
MEK
MAPK
7892.012
uM
inf
0.05174
0.5884 0.6799 2.1441 0.1234
0.9280
2.3881
MDA-MB-231
TNBC
Basal B
Trametinib
MEK
MAPK
7893.05
uM
inf
0.04861
0.5318 0.5810 1.7706 0.1712
0.9746
2.2255
MDA-MB-231
TNBC
Basal B
Trichostatin A
HDAC
HDAC
7504.065
uM
24.38210
29.18280
-0.9183 -0.7281 5.0000 0.6791
0.9880
1.6220
MDA-MB-231
TNBC
Basal B
Triciribine
AKT
AKT
7504.074
uM
inf
6.09780
0.5573 0.5504 2.4534 0.0410
0.9267
1.8962
MDA-MB-231
TNBC
Basal B
Vinorelbine
TUBB
TUBB
7893.042
uM
0.02305
3.08920
-0.7080 -1.0000 0.2243 0.6339
0.7254
2.2789